Trials / Completed
CompletedNCT01065220
Sex Steroids and the Serotonin Transporter
The Influence of Sex Steroid Hormones on Serotonin Transporter Binding in the Human Brain Investigated by Positron Emission Tomography
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Medical University of Vienna · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to prove the influence of the sex steroid hormones estrogen, progesterone and testosterone on the serotonin transporter (5-HTT) binding using positron emission tomography (PET) and the selective radioligand \[11C\]DASB. Specifically, the 5-HTT binding will be quantified before and after hormone therapy underwent by 10 male-to-female (MtF) and 10 female-to-male (FtM) transsexuals urging for hormone treatment. The high-level, long-term administration of opsite sex steroid hormones in transsexuals provide the unique opportunity to investigate the influence of sex steroid hormones on the serotonergic system. Since the serotonin transporter serves as a primary target molecule for antidepressant treatment, the results of the study will be of benefit for the assessment of the clinical relevance of estrogen and testosterone as modulatory and neuroactive agents.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testolactone undecanoate | 4ml i.m. |
| DRUG | Lynestrenol | 2/day |
| DRUG | Cyproterone Acetate | 50mg per day |
| DRUG | Estradiol | 100 microgram TTS twice a week |
| DRUG | 5-alpha reductase inhibitor | 1mg daily |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2014-01-01
- Completion
- 2014-01-01
- First posted
- 2010-02-09
- Last updated
- 2014-01-03
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT01065220. Inclusion in this directory is not an endorsement.